Optimal condition of heparin-conjugated fibrin with bone morphogenetic protein-2 for spinal fusion in a rabbit model
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Jab-Young | - |
dc.contributor.author | Kang, Sun-Woong | - |
dc.contributor.author | Kim, Jung-Wook | - |
dc.contributor.author | Suh, Seung-Woo | - |
dc.contributor.author | Ko, You-Jin | - |
dc.contributor.author | Park, Jung-Ho | - |
dc.date.accessioned | 2021-09-05T04:42:45Z | - |
dc.date.available | 2021-09-05T04:42:45Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-10 | - |
dc.identifier.issn | 1465-3249 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97281 | - |
dc.description.abstract | Background aims. Heparin-conjugated fibrin (HCF) is a carrier for long-term release of bone morphogenetic protein-2 (BMP-2) and has been shown to promote bone formation in animal models. We performed an experimental study to determine the optimal dose of BMP-2 with an HCF carrier that promotes bone formation comparable to that of autograft while minimizing complications in spinal fusion. Methods. Twenty-four rabbits underwent posterolateral fusion of the L5-6 spinal segments. Different concentrations of HCF BMP-2 (1/10, 1/20, 1/30 or 1/40) were implanted in the spines of experimental rabbits, and autograft or INFUSE was implanted in the spines of control animals. Eight weeks after treatment, spinal fusion efficacy was evaluated by plain radiography, micro-computed tomography (micro-CT), mechanical testing and histomorphometry. Results. Similar to autograft, the 1/40 HCF BMP-2 showed significant bone formation on micro-CT and histomorphometry with mechanical stability. However, the other HCF BMP-2 concentrations did not show significant bone formation compared with autograft. Although conventional BMP-2 (INFUSE) led to higher bone formation and stability, it also led to excessive ectopic bone and fibrous tissue formation. Conclusions. This study suggests the optimal concentration of BMP-2 using HCF for spinal fusion, which may decrease the complications of high-dose conventional BMP-2. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.subject | LONG-TERM DELIVERY | - |
dc.subject | SUSTAINED DELIVERY | - |
dc.subject | ENHANCEMENT | - |
dc.subject | SUBSTITUTE | - |
dc.subject | EFFICACY | - |
dc.subject | TRENDS | - |
dc.title | Optimal condition of heparin-conjugated fibrin with bone morphogenetic protein-2 for spinal fusion in a rabbit model | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hong, Jab-Young | - |
dc.contributor.affiliatedAuthor | Suh, Seung-Woo | - |
dc.contributor.affiliatedAuthor | Park, Jung-Ho | - |
dc.identifier.doi | 10.1016/j.jcyt.2014.04.005 | - |
dc.identifier.scopusid | 2-s2.0-84908509079 | - |
dc.identifier.wosid | 000342396800012 | - |
dc.identifier.bibliographicCitation | CYTOTHERAPY, v.16, no.10, pp.1441 - 1448 | - |
dc.relation.isPartOf | CYTOTHERAPY | - |
dc.citation.title | CYTOTHERAPY | - |
dc.citation.volume | 16 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1441 | - |
dc.citation.endPage | 1448 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | LONG-TERM DELIVERY | - |
dc.subject.keywordPlus | SUSTAINED DELIVERY | - |
dc.subject.keywordPlus | ENHANCEMENT | - |
dc.subject.keywordPlus | SUBSTITUTE | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | TRENDS | - |
dc.subject.keywordAuthor | autograft | - |
dc.subject.keywordAuthor | BMP-2 | - |
dc.subject.keywordAuthor | heparin-conjugated fibrin | - |
dc.subject.keywordAuthor | spinal fusion | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.